Management of neurosarcoidosis: a clinical challenge
Authors:
Open Access
- 1 June 2019
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Neurology
- Vol. 32 (3) , 475-483
Abstract
Purpose of review: Sarcoidosis is a complex disease with many faces, and the clinical manifestation and course of neurosarcoidosis are particularly variable. Although neurosarcoidosis occurs in up to 10% of sarcoidosis patients, it can lead to significant morbidity and some mortality. Recent findings: Three criteria are usually required for a diagnosis of (neuro)sarcoidosis: clinical and radiologic manifestations, noncaseating granulomas, and no evidence of alternative disease. Recent guidelines have helped to clarify criteria for diagnosing neurosarcoidosis. No firm guidelines exist on whether, when, and how treatment should be started. Treatment depends on the presentation and distribution, extensiveness, and severity of neurosarcoidosis. As regards evidence-based treatment, only a few randomized controlled trials have been done. Hence, several aspects of (neuro)sarcoidosis management are not fully addressed by the current literature. Summary: Significant advances have been made in the potential and accuracy of diagnostics for neurosarcoidosis. Treatment should be approached within the context of the patient's anticipated clinical course, avoidance of adverse drug effects, and, if necessary, from the perspective of the comprehensive management of a chronic disease. A multidisciplinary approach to the management of sarcoidosis is strongly recommended.Keywords
This publication has 78 references indexed in Scilit:
- Prediction of relapse after discontinuation of infliximab therapy in severe sarcoidosisEuropean Respiratory Journal, 2013
- Rituximab for refractory granulomatous eye diseaseClinical Ophthalmology, 2012
- Sarcoidosis-associated fatigueEuropean Respiratory Journal, 2012
- Mycophenolate mofetil may be effective in CNS sarcoidosis but not in sarcoid myopathyNeurology, 2011
- Corneal Confocal MicroscopyDiabetes Care, 2010
- Everyday Cognitive Failure in Sarcoidosis: The Prevalence and the Effect of Anti-TNF-α TreatmentRespiration, 2010
- Small fiber neuropathy: A burning problemCleveland Clinic Journal of Medicine, 2009
- Infliximab therapy rescues cyclophosphamide failure in severe central nervous system sarcoidosisRespiratory Medicine, 2009
- Measuring fatigue in sarcoidosis: The Fatigue Assessment Scale (FAS)British Journal of Health Psychology, 2004
- The Cognitive Failures Questionnaire (CFQ) and its correlatesBritish Journal of Clinical Psychology, 1982